Akari Therapeutics Plc (AKTX) › Total LiabilitiesAkari Therapeutics Plc (AKTX) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2014: $1.17M2015: $21.17M2016: $11.77M2017: $11.90M2018: $4.92M2019: $6.47M2020: $5.22M2021: $6.09M2022: $12.04M2023: $4.58M2024: $28.33M2025: $19.56M$19.56M2014Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$19.56M-30.9%2024$28.33M+518.1%2023$4.58M-61.9%2022$12.04M+97.6%2021$6.09M+16.7%2020$5.22M-19.3%2019$6.47M+31.6%2018$4.92M-58.7%2017$11.90M+1.1%2016$11.77M-44.4%2015$21.17M+1707.6%2014$1.17M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share